Skip to main content
Have a personal or library account? Click to login
Microbial Signatures in Head and Neck versus Gastrointestinal Tumors: Identification and Prognostic Modeling Cover

Microbial Signatures in Head and Neck versus Gastrointestinal Tumors: Identification and Prognostic Modeling

By: ,  ,   and    
Open Access
|Jun 2026

References

  1. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB. 2012. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 338(6103):120–123. https://doi.org/10.1126/science.1224820
  2. Asili P, Mirahmad M, Rezaei P, Mahdavi M, Larijani B, Tavangar SM. 2023. The association of oral microbiome dysbiosis with gastrointestinal cancers and its diagnostic efficacy. J Gastrointest Cancer. 54(4):1082–1101. https://doi.org/10.1007/s12029-023-00935-2
  3. Battaglia TW, Mimpen IL, Traets JJH, van Hoeck A, Zeverijn LJ, Geurts BS, de Wit GF, Noё M, Hofland I, Vos JL. 2024. A pan-cancer analysis of the microbiome in metastatic cancer. Cell. 187(9):2324–2335.e19. https://doi.otg/10.1016Zj.cell.2024.02.012
  4. Cao Y, Xia H, Tan X, Shi C, Ma Y, Meng D, Zhou M, Lv Z, Wang S, Jin Y. 2024. Intratumoural microbiota: a new frontier in cancer development and therapy. Signal Transduct Target Ther. 9(1): 15. https://doi.org/10.1038/s41392-023-01659-2
  5. Chaudhary K, Poirion OB, Lu L, Garmire LX. 2018. Deep learning-based multi-omics integration robustly predicts survival in liver cancer. Clin Cancer Res. 24(6):1248–1259. https://doi.org/10.1158/1078-0432.CCR-17-0853
  6. Conway JR, Lex A, Gehlenborg N. 2017. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics. 33(18):2938–2940. https://doi.org/10.1093/bioinformatics/btx364
  7. Deist TM, Dankers F, Valdes G, Wijsman R, Hsu IC, Oberije C, Lustberg T, van Soest J, Hoebers F, Jochems A. 2018. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: an empirical comparison of classifiers. Med Phys. 45(7):3449–3459. https://doi.org/10.1002/mp.12967
  8. Dohlman AB, Arguijo Mendoza D, Ding S, Gao M, Dressman H, Iliev ID, Lipkin SM, Shen X. 2021. The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants. Cell Host Microbe. 29(2):281–298.e5. https://doi.org/10.1016/j.chom.2020.12.001
  9. Elghannam MT, Hassanien MH, Ameen YA, Turky EA, El-GM E, El-AA E, El-MD E. 2025. Gut microbiome and gastric cancer: microbial interactions and therapeutic potential. Gut Pathog. 17(1):56. https://doi.org/10.1186/s13099-025-00586-4
  10. Elinav E, Garrett WS, Trinchieri G, Wargo J. 2019. The cancer microbiome. Nat Rev Cancer. 19(7):371–376. https://doi.org/10.1038/s41568-019-0155-3
  11. Flemer B, Warren RD, Barrett MP, Cisek K, Das A, Jeffery IB, Hurley E, O’Riordain M, Shanahan F, O’Toole PW. 2018. The oral microbiota in colorectal cancer is distinctive and predictive. Gut. 67(8):1454–1463. https://doi.org/10.1136/gutjnl-2017-314814
  12. Galeano Niño JL, Wu H, LaCourse KD, Kempchinsky AG, Baryiames A, Barber B, Futran N, Houlton J, Sather C, Sicinska E. 2022. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 611(7937):810–817. https://doi.org/10.1038/s41586-022-05435-0
  13. Gill PA, Inniss S, Kumagai T, Rahman FZ, Smith AM. 2022. The role of diet and gut microbiota in regulating gastrointestinal and inflammatory disease. Front Immunol. 13:866059. https://doi.org/10.3389/fimmu.2022.866059
  14. Goeman JJ. 2010. L1 penalized estimation in the Cox proportional hazards model. Biom J. 52(1):70–84. https://doi.org/10.1002/bimj.200900028
  15. Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. 2018. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell. 33(4):570–580. https://doi.org/10.1016/j.ccell.2018.03.015
  16. He J, Li H, Jia J, Liu Y, Zhang N, Wang R, Qu W, Liu Y, Jia L. 2023. Mechanisms by which the intestinal microbiota affects gastrointestinal tumours and therapeutic effects. Mol Biomed. 4(1):45. https://doi.org/10.1186/s43556-023-00128-3
  17. Hodgkinson K, El Abbar F, Dobranowski P, Manoogian J, Butcher J, Figeys D, Mack D, Stintzi A. 2023. Butyrate’s role in human health and progress towards clinical application. Clin Nutr. 42(2):61–75. https://doi.org/10.1016/j.clnu.2022.11.004
  18. Hold GL. 2016. Gastrointestinal microbiota and colon cancer. Dig Dis. 34(3):244–250. https://doi.org/10.1159/000443357
  19. Hollister EB, Gao C, Versalovic J. 2014. Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology. 146(6):1449–1458. https://doi.org/10.1053/j.gastro.2014.01.052
  20. Hunt RH, Camilleri M, Crowe SE, El-Omar EM, Fox JG, Kuipers EJ, Malfertheiner P, McColl KE, Pritchard DM, Rugge M. 2015. The stomach in health and disease. Gut. 64(10):1650–1668. https://doi.org/10.1136/gutjnl-2014-307595
  21. Inamura K. 2021. Gut microbiota contributes towards immunomodulation against cancer. Semin Cancer Biol. 70:11–23. https://doi.org/10.1016/j.semcancer.2020.05.008
  22. Jiang K, Pang X, Li W, Xu X, Yang Y, Shang C, Gao X. 2025. Interbacterial warfare in the human gut: insights from Bacteroidales perspective. Gut Microbes. 17(1):2473522. https://doi.org/10.1080/19490976.2025.2473522
  23. John Kenneth M, Tsai HC, Fang CY, Hussain B, Chiu YC, Hsu BM. 2023. Diet-mediated gut microbial modulation and metabolites as biomarkers in colorectal cancer. J Adv Res. 52:45–57. https://doi.org/10.1016/j.jare.2023.05.002
  24. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL. 2013. Fusobacterium nucleatum potentiates intestinal tumorigenesis. Cell Host Microbe. 14(2):207–215. https://doi.org/10.1016/j.chom.2013.07.007
  25. La Rosa GRM, Gattuso G, Pedullà E, Rapisarda E, Nicolosi D, Salmeri M. 2020. Association of oral dysbiosis with oral cancer development. Oncol Lett. 19(4):3045–3058. https://doi.org/10.3892/ol.2020.11383
  26. Lawal FJ, Baer SL. 2021. Capnocytophaga gingivalis bacteremia after gastrointestinal bleeding. J Investig Med High Impact Case Rep. 9:23247096211020672. https://doi.org/10.1177/23247096211020672
  27. Li Y, Wei B, Xue X, Li H, Li J. 2023. Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis. Cancer Biol Med. 21(2):163–174. https://doi.org/10.20892/j.issn.2095-3941.2023.0093
  28. Liu G, Li T, Zhu X, Zhang X, Wang J. 2023. Evaluation of microbiome 16S rRNA analysis methods in CRC. Front Microbiol. 14:1178744. https://doi.org/10.3389/fmicb.2023.1178744
  29. Lo SH, Chang YY, Jao YT, Wang WH, Lu PL, Chen YH. 2018. Capnocytophaga sputigena pneumonia and bacteremia. J Microbiol Immunol Infect. 51(4):578–579. https://doi.org/10.1016/j.jmii.2017.08.017
  30. Metsaniitty M, Hasnat S, Salo T, Salem A. 2021. Oral microbiota: a new frontier in the pathogenesis and management of head and neck cancers. Cancers (Basel). 14(1):1–18. https://doi.org/10.3390/cancers14010001
  31. Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E. 2020. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 368(6494):973–980. https://doi.org/10.1126/science.aay9189
  32. Nouri Z, Choi SW, Choi IJ, Ryu KW, Woo SM, Park SJ, Lee WJ, Choi W, Jung YS, Myung SK. 2023. Exploring connections between oral microbiota, short-chain fatty acids, and specific cancer types. Cancers (Basel). 15(11):2898. https://doi.org/10.3390/cancers15112898
  33. Pan X, Jin X, Wang J, Hu Q, Dai B. 2021. Placenta inflammation is closely associated with gestational diabetes mellitus. Am J Transl Res. 13(5):4068–4079.
  34. Poniżej masz blok 31–60 z pliku opracowany zgodnie z wymaganiami (CSE + CrossRef + NLM):
  35. Recharla N, Geesala R, Shi XZ. 2023. Gut microbial metabolite butyrate and its therapeutic role in inflammatory bowel disease: a literature review. Nutrients. 15(10):2300. https://doi.org/10.3390/nu15102300
  36. Rizzo A, Santoni M, Mollica V, Fiorentino M, Brandi G, Massari F. 2022. Microbiota and prostate cancer. Semin Cancer Biol. 86(Pt 3):1058–1065. https://doi.org/10.1016/j.semcancer.2021.03.006
  37. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M. 2011. pROC: an open-source package for R to analyze and compare ROC curves. BMC Bioinformatics. 12:77. https://doi.org/10.1186/1471-2105-12-77
  38. Sears CL, Garrett WS. 2014. Microbes, microbiota, and colon cancer. Cell Host Microbe. 15(3):317–328. https://doi.org/10.1016/j.chom.2014.02.007
  39. Shang Q, Shi J, Song G, Zhang M, Cai C, Hao J, Li G, Yu G. 2016. Structural modulation of gut microbiota by chondroitin sulfate. Int J Biol Macromol. 89:489–498. https://doi.org/10.1016/j.ijbiomac.2016.05.002
  40. Shao D, Vogtmann E, Liu A, Qin J, Chen W, Abnet CC, Wei WQ. 2019. Microbial characterization of esophageal squamous cell carcinoma. Cancer. 125(22):3993–4002. https://doi.org/10.1002/cncr.32416
  41. Sheh A, Fox JG. 2013. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes. 4(6):505–531. https://doi.org/10.4161/gmic.26205
  42. Shin H, Mally M, Kuhn M, Paroz C, Cornelis GR. 2007. Escape from immune surveillance by Capnocytophaga canimorsus. J Infect Dis. 195(3):375–386. https://doi.org/10.1086/510858
  43. Sobstyl M, Brecht P, Sobstyl A, Mertowska P, Grywalska E. 2022. The role of microbiota in the immunopathogenesis of endometrial cancer. Int J Mol Sci. 23(10):5668. https://doi.org/10.3390/ijms23105668
  44. Stasiewicz M, Karpiński TM. 2022. The oral microbiota and its role in carcinogenesis. Semin Cancer Biol. 86(Pt 3):633–642. https://doi.org/10.1016/j.semcancer.2021.06.002
  45. Sun CH, Li BB, Wang B, Zhao J, Zhang XY, Li TT, Li WB, Tang D, Qiu MJ, Wang XC. 2019. The role of Fusobacterium nucleatum in colorectal cancer. Chronic Dis Transl Med. 5(3):178–187. https://doi.org/10.1016/j.cdtm.2019.07.007
  46. Tomczak K, Czerwińska P, Wiznerowicz M. 2015. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 19(1A):A68–A77. https://doi.org/10.5114/wo.2014.47136
  47. Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M. 2020. The controversial role of human gut Lachnospiraceae. Microorganisms. 8(4):573. https://doi.org/10.3390/microorganisms8040573
  48. Wang C, Zhao J, Zhang H, Lee YK, Zhai Q, Chen W. 2021. Roles of intestinal Bacteroides in human health and diseases. Crit Rev Food Sci Nutr. 61(21):3518–3536. https://doi.org/10.1080/10408398.2020.1809346
  49. Wang J, Wang Y, Li Z, Gao X, Huang D. 2021. Global analysis of microbiota signatures in gastrointestinal cancers. Front Oncol. 11:685641. https://doi.org/10.3389/fonc.2021.685641
  50. Wang P, Wang Y, Hang B, Zou X, Mao JH. 2016. Gene expression-based prognostic scoring system in gastric cancer. Oncotarget. 7(34):55343–55351. https://doi.org/10.18632/oncotarget.10543
  51. Wang Q, Liu X. 2015. Screening of feature genes distinguishing breast cancer types. Onco Targets Ther. 8:2311–2317. https://doi.org/10.2147/OTT.S89287
  52. Xie W, Sharma A, Kaushik H, Sharma L, Anwer MK, Sachdeva M, Elossaily GM, Zhang Y, Pillappan R, Kaur M. 2024. Shaping the future of gastrointestinal cancers through metabolic interactions with gut microbiota. Heliyon. 10(15):e35336. https://doi.org/10.1016/j.heliyon.2024.e35336
  53. Yang K, Li G, Li Q, Wang W, Zhao X, Shao N, Qiu H, Liu J, Xu L, Zhao J. 2025. Distribution of gut microbiota across intestinal segments and their impact on physiology. Cell Biosci. 15(1):47. https://doi.org/10.1186/s13578-025-01147-3
  54. Yang L, Li A, Wang Y, Zhang Y. 2023. Intratumoral microbiota: roles in cancer initiation and therapy. Signal Transduct Target Ther. 8(1):35. https://doi.org/10.1038/s41392-022-01277-9
  55. Zafar H, Saier MH Jr. 2021. Gut Bacteroides species in health and disease. Gut Microbes. 13(1):1–20. https://doi.org/10.1080/19490976.2020.1848158
  56. Zhang H, Miyake T, Maekawa T, Mori H, Yasukawa D, Ohno M, Nishida A, Andoh A, Tani M. 2023. High abundance of Lachnospiraceae in the human gut microbiome is related to high immunoscores in colorectal cancer. Cancer Immunol Immunother. 72(2):315–326. https://doi.org/10.1007/s00262-022-03263-7
  57. Zhao LY, Mei JX, Yu G, Lei L, Zhang WH, Liu K, Chen XL, Kołat D, Yang K, Hu JK. 2023. Role of gut microbiota in anticancer therapy. Signal Transduct Target Ther. 8(1):201. https://doi.org/10.1038/s41392-023-01452-1
  58. Zhou J, Sun S, Luan S, Xiao X, Yang Y, Mao C, Chen L, Zeng X, Zhang Y, Yuan Y. 2021. Gut microbiota for esophageal cancer: role in carcinogenesis. Front Oncol. 11:717242. https://doi.org/10.3389/fonc.2021.717242
  59. Zhu W, Shen W, Wang J, Xu Y, Zhai R, Zhang J, Wang M, Wang M, Liu L. 2024. Capnocytophaga gingivalis as a potential tumor promoter in oral cancer. Oral Dis. 30(2):353–362. https://doi.org/10.1111/odi.14456
  60. Zitomersky NL, Coyne MJ, Comstock LE. 2011. Longitudinal analysis of Bacteroidales species in the human gut. Infect Immun. 79(5):2012–2020. https://doi.org/10.1128/IAI.01377-10
DOI: https://doi.org/10.33073/pjm-2026-012 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 123 - 138
Submitted on: Nov 22, 2025
Accepted on: Mar 10, 2026
Published on: Jun 30, 2026
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Hua Guo, Jihan Wang, Yaqi Niu, Fuqiang Liu, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.